Table 2.
Results PCR screening. Bats were screened for the presence of virus nucleic acids by different PCR assays.
| PCR assays | Assay type | Bats #/novel/size* |
Assay reference | Virus reference |
|---|---|---|---|---|
| Adenoviridae | ||||
| Adenoviridae (Polymerase) | Pan | 79/14/203H | (67) | (31) |
| Arenaviridae | ||||
| Old-World | Pan | 0/0/60 | (61) | Unpublished |
| Bunyaviridae | ||||
| Hanta Virus Puumala | cPCR | 0/0/150 | In-house design RKI | (71) |
| Hanta Virus Dobrava | cPCR | 0/0/150 | In-house design RKI | (71) |
| Hanta Virus Tula | cPCR | 0/0/150 | In-house design RKI | (71) |
| Hantaviruses | Pan | 0/0/180 | (64) | Unpublished |
| Nairoviruses | Pan | 0/0/150 | (65) | Unpublished |
| Phleboviruses | Pan | 0/0/150 | (65) | Unpublished |
| Coronaviridae | ||||
| Coronaviridae | Pan | 1/1/240 | (35) | Unpublished (MN851285) |
| Coronaviridae | Pan | 0/0/90 | In-house design RKI | unpublished |
| Flaviviridae | ||||
| Flaviviridae | Pan | 0/0/150 | In-house design | Unpublished |
| Flaviviridae | Pan | 0/0/180 | (63) | (71) |
| Herpesviridae | ||||
| BatGHV1 | cPCR | 1/1/180 | (34) | (71) |
| BatGHV3 | cPCR | 7/1/180 | (34) | (71) |
| BatGHV4 | cPCR | 22/1/210 | (34) | (71) |
| BatGHV5 | cPCR | 11/1/210 | (34) | (71) |
| BatGHV6 | cPCR | 24/1/210 | (34) | (71) |
| BatGHV7 | cPCR | 2/1/210 | (34) | (71) |
| BatBHV1 | cPCR | 1/1/180 | (34) | (71) |
| Herpesviridae | pan | 11/9/60 | (68) | Unpublished |
| Orthomyxoviridae | ||||
| Influenza A | qPCR | 0/0/330 | (66) | – |
| Paramyxoviridae | ||||
| Res-Mor-Hen | Pan | 2/2/120 | (60) | (32) |
| PAR | Pan | 3/3/180 | (60) | (32) |
| Poxviridae | ||||
| Low GC poxviruses | Pan | 0/0/263 | (70) | Unpublished |
pan generic family-specific assay, qPCR quantitative real-time PCR, cPCR conventional specific PCR. *#/novel/size: #, number of positive samples; novel, number of novel viruses obtained; size, bat sample size. HScreened in collaboration with our Hungarian colleagues (see Ref.33).